Takeda Pharmaceutical Co(JP:4502)
¥6,825.00+152.00 (+2.28%)
JP:4502
Takeda Pharmaceutical Co earnings date
¥6,825.00
At close:+152.00 (+2.28%)
Want to see JP:4502 full AI Analyst Report?
Takeda Pharmaceutical Co (4502) Q2 2024 Earnings Report
10 Followers
JP:4502 Q2 2024 EPS Results
- Actual EPS
- JPY 58.21
- Consensus EPS
- JPY 37.05
- Beat/Miss
- Beat by +JPY 21.17
- One Year Ago EPS
- -JPY 31.00
JP:4502 Q2 2024 Revenue Results
- Actual Revenue
- JPY 1.18T
- Expected Revenue
- JPY 1.09T
- Beat/Miss
- Beat by +JPY 87.05B
- YoY Revenue Growth
- +12.75%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 10/31/2024
- Time
- Before Open
- Conference Call
- Thursday, October 31, 2024
JP:4502 Upcoming Earnings
Takeda Pharmaceutical Co's next earnings date is estimated for January 28, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
JP:4502 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
JP:4502 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 28, 2027 | 2026 (Q3) | 44.55- | 65.74 | ― | ― |
| Oct 29, 2026 | 2026 (Q2) | 45.38120.88 | -7.83 | 1643.81% (+128.71) | |
| Jul 30, 2026 | 2026 (Q1) | 54.3871.65 | 79.4 | -9.76% (-7.75) | |
| May 13, 2026 | 2025 (Q4) | -24.02-15.56 | -66 | 76.42% (+50.44) | |
| Jan 28, 2026 | 2025 (Q3) | 43.1465.74 | 15.15 | 333.93% (+50.59) | |
| Oct 30, 2025 | 2025 (Q2) | 20.73-7.83 | 58.21 | -113.45% (-66.04) | |
| Jul 30, 2025 | 2025 (Q1) | 49.5679.40 | 61 | 30.16% (+18.40) | |
| May 08, 2025 | 2024 (Q4) | -8.84-66.00 | -2.1 | -3042.86% (-63.90) | |
| Jan 30, 2025 | 2024 (Q3) | 26.2015.15 | 67.59 | -77.59% (-52.44) | |
| Oct 31, 2024 | 2024 (Q2) | 37.0558.21 | -31 | 287.77% (+89.21) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
